Login / Signup
Post-alemtuzumab Graves' disease remitting after switch to ocrelizumab.
Veronica Popescu
Annemie Beirinckx
Brigitte Decallonne
Published in:
Acta neurologica Belgica (2022)
Keyphrases
</>
multiple sclerosis
disease activity
rheumatoid arthritis
systemic lupus erythematosus